Bill C-224: Briefs

Key requirements include:

• Content: Provide factual information and clearly support all views and claims. Recommendations—especially any suggested amendments—must be specific and summarized at the end of the brief.

• Length: Briefs should generally not exceed 10 pages. If longer, include a summary of no more than 500 words. The committee may translate and publish only the summary.

• Identification: Clearly indicate the name of the author or organization on the cover page. Organizations must include a general description of themselves at the end.

• Citations: Use footnotes or a bibliography for all quoted or referenced materials.

• Visuals: Render photographs, logos, graphics, tables, and charts in black and white only. Provide them in both official languages if possible.

• Official Guide: Full parliamentary guidelines are available here

• Share your personal health story: Describe prior health challenges, why conventional options didn’t work, and how NHPs helped you recover or stay well.

• Emphasize that many Canadians are alive and healthy today thanks to natural health products.

• Highlight the benefits of NHPs, not just “risk management.”

• Mention if you have lost access to products or must order them from the U.S.

• Express concern about over-regulation making essential nutrients too expensive or unavailable, especially for disadvantaged Canadians.

• State clearly that you want the committee to pass Bill C-224 without amendments.

• Life and Death Issue — Access to NHPs is essential for many Canadians. Over 70% of Canadians use natural health products. Restricting them puts health at risk. Videos and stories from the World’s Greatest Health Show (available at nhppa.org) demonstrate this clearly.
• Essential Nutrients Are Not Dangerous Drugs — Classifying vitamin C, vitamin D, or ginger tea alongside drugs like Thalidomide or Vioxx is misguided. NHPs were not regulated as drugs before 2004 and are treated as foods in the U.S. under the Dietary Supplement Health and Education Act (1994).
• $5 Million Daily Fines Are Inappropriate — These penalties, designed for large pharmaceutical companies, are devastating for small natural health businesses and practitioners. They have already led to self-censorship of truthful health information.
• Double Standard — No major pharmaceutical company has ever been charged under the Food and Drugs Act in Canadian history, despite prescription drugs being linked to significant harm (including being cited as a leading cause of death when taken as directed). Yet natural health companies and practitioners face aggressive enforcement.
• Health Is Our Greatest Asset — Canadians can no longer get all needed nutrients from food alone. Laws should promote access to vital supplements, not treat them like high-risk chemicals.
• Recalls Without Court Oversight Are Problematic — Allowing bureaucrats to order recalls without judicial review interferes with medical decisions and patient care. Court supervision would better balance risks and protect those who rely on specific products (as seen in past cases).
• The Nicotine Exception — Bill C-224 already allows nicotine products to be treated differently. No amendments are needed to address youth protection concerns.